LMNL Annual Gross Profit
N/A
31 December 2022
Summary:
LMNL annual gross profit is not available.LMNL Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LMNL Quarterly Gross Profit
N/A
30 June 2023
Summary:
LMNL quarterly gross profit is not available.LMNL Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LMNL TTM Gross Profit
N/A
30 June 2023
Summary:
LMNL TTM gross profit is not available.LMNL TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LMNL Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
LMNL Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Liminal BioSciences Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $238.40 K(+87.7%) | -$4.40 M(+92.8%) |
| June 2019 | - | $127.00 K(-85.1%) | -$2.28 M(-560.5%) |
| Mar 2019 | - | $852.60 K(-115.2%) | $495.70 K(-167.7%) |
| Dec 2018 | -$828.80 K(-105.8%) | -$5.62 M(-338.4%) | -$732.20 K(-2305.4%) |
| Sept 2018 | - | $2.36 M(-18.9%) | $33.20 K(-99.8%) |
| June 2018 | - | $2.91 M(-874.1%) | $13.83 M(+11.0%) |
| Mar 2018 | - | -$375.30 K(-92.3%) | $12.47 M(-15.3%) |
| Dec 2017 | $14.37 M(+117.2%) | -$4.85 M(-130.0%) | $14.71 M(-29.4%) |
| Sept 2017 | - | $16.16 M(+951.1%) | $20.83 M(+240.3%) |
| June 2017 | - | $1.54 M(-17.8%) | $6.12 M(+3.4%) |
| Mar 2017 | - | $1.87 M(+47.2%) | $5.92 M(-9.9%) |
| Dec 2016 | $6.61 M(-48.3%) | $1.27 M(-12.1%) | $6.57 M(-46.1%) |
| Sept 2016 | - | $1.45 M(+8.0%) | $12.18 M(-13.9%) |
| June 2016 | - | $1.34 M(-46.9%) | $14.14 M(+0.2%) |
| Mar 2016 | - | $2.52 M(-63.4%) | $14.11 M(+13.3%) |
| Dec 2015 | $12.78 M(-11.8%) | $6.88 M(+102.0%) | $12.45 M(-2.5%) |
| Sept 2015 | - | $3.41 M(+161.2%) | $12.77 M(+19.4%) |
| June 2015 | - | $1.30 M(+51.3%) | $10.70 M(-7.7%) |
| Mar 2015 | - | $861.80 K(-88.0%) | $11.59 M(-19.1%) |
| Dec 2014 | $14.49 M(+6.8%) | $7.20 M(+441.6%) | $14.32 M(+42.5%) |
| Sept 2014 | - | $1.33 M(-39.4%) | $10.05 M(-22.5%) |
| June 2014 | - | $2.20 M(-38.9%) | $12.97 M(-7.9%) |
| Mar 2014 | - | $3.59 M(+22.7%) | $14.08 M(+3.9%) |
| Dec 2013 | $13.57 M(-24.5%) | $2.93 M(-31.1%) | $13.56 M(-20.7%) |
| Sept 2013 | - | $4.25 M(+28.2%) | $17.11 M(-11.4%) |
| June 2013 | - | $3.31 M(+7.9%) | $19.32 M(-7.7%) |
| Mar 2013 | - | $3.07 M(-52.6%) | $20.93 M(+16.3%) |
| Dec 2012 | $17.98 M(+13.0%) | $6.47 M(+0.2%) | $18.00 M(-5.9%) |
| Sept 2012 | - | $6.46 M(+31.1%) | $19.12 M(+22.4%) |
| June 2012 | - | $4.93 M(+3349.6%) | $15.63 M(+16.2%) |
| Mar 2012 | - | $142.80 K(-98.1%) | $13.45 M(-14.6%) |
| Dec 2011 | $15.91 M(+90.7%) | $7.59 M(+156.0%) | $15.74 M(+79.8%) |
| Sept 2011 | - | $2.97 M(+8.1%) | $8.76 M(+13.6%) |
| June 2011 | - | $2.74 M(+12.6%) | $7.71 M(-12.9%) |
| Mar 2011 | - | $2.44 M(+299.5%) | $8.85 M(+6.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2010 | $8.34 M(-9.4%) | $610.00 K(-68.2%) | $8.33 M(-22.2%) |
| Sept 2010 | - | $1.92 M(-50.7%) | $10.72 M(-4.5%) |
| June 2010 | - | $3.88 M(+101.6%) | $11.22 M(+98.3%) |
| Mar 2010 | - | $1.93 M(-35.6%) | $5.66 M(-12.8%) |
| Dec 2009 | $9.21 M(+17.8%) | $2.99 M(+23.8%) | $6.49 M(-7.2%) |
| Sept 2009 | - | $2.42 M(-244.0%) | $6.99 M(+3.7%) |
| June 2009 | - | -$1.68 M(-160.9%) | $6.74 M(-25.1%) |
| Mar 2009 | - | $2.76 M(-21.1%) | $9.00 M(+20.8%) |
| Dec 2008 | $7.81 M(-1365.5%) | $3.50 M(+61.5%) | $7.45 M(+88.4%) |
| Sept 2008 | - | $2.16 M(+271.8%) | $3.95 M(+121.1%) |
| June 2008 | - | $582.20 K(-51.7%) | $1.79 M(+48.3%) |
| Mar 2008 | - | $1.21 M(-45.3%) | $1.21 M(-45.3%) |
| Mar 2007 | - | $2.20 M(-315.5%) | $2.20 M(-288.3%) |
| June 2003 | - | -$1.02 M(+592.3%) | -$1.17 M(-0.3%) |
| Sept 2002 | - | -$147.60 K(-75.0%) | -$1.17 M(+13.9%) |
| June 2002 | - | -$591.30 K(+19.2%) | -$1.03 M(+25.2%) |
| Mar 2002 | - | -$495.90 K(-898.6%) | -$822.40 K(+31.6%) |
| Dec 2001 | -$617.50 K(+28.4%) | $62.10 K(-1544.2%) | -$624.70 K(-16.5%) |
| Sept 2001 | - | -$4300.00(-98.9%) | -$748.20 K(-35.8%) |
| June 2001 | - | -$384.30 K(+28.9%) | -$1.17 M(+4.2%) |
| Mar 2001 | - | -$298.20 K(+385.7%) | -$1.12 M(-3.9%) |
| Dec 2000 | -$481.00 K(-66.0%) | -$61.40 K(-85.4%) | -$1.16 M(-59.4%) |
| Sept 2000 | - | -$421.10 K(+24.7%) | -$2.87 M(+27.7%) |
| June 2000 | - | -$337.70 K(-1.8%) | -$2.25 M(-21.4%) |
| Mar 2000 | - | -$344.00 K(-80.5%) | -$2.86 M(-13.6%) |
| Dec 1999 | -$1.41 M(-4.8%) | -$1.77 M(-975.3%) | -$3.31 M(+0.5%) |
| Sept 1999 | - | $201.80 K(-121.2%) | -$3.29 M(-0.1%) |
| June 1999 | - | -$950.50 K(+19.8%) | -$3.30 M(+40.5%) |
| Mar 1999 | - | -$793.40 K(-54.7%) | -$2.35 M(+51.1%) |
| Dec 1998 | -$1.49 M(+190.6%) | -$1.75 M(-983.5%) | -$1.55 M(+1709.8%) |
| Sept 1998 | - | $198.20 K(>+9900.0%) | -$85.80 K(-69.8%) |
| June 1998 | - | $0.00(0.0%) | -$284.00 K(0.0%) |
| Mar 1998 | - | $0.00(-100.0%) | -$284.00 K(0.0%) |
| Dec 1997 | - | -$284.00 K | -$284.00 K |
| Sept 1997 | -$511.10 K | - | - |
FAQ
- What is the all time high annual gross profit for Liminal BioSciences?
- What is the all time high quarterly gross profit for Liminal BioSciences?
- What is the all time high TTM gross profit for Liminal BioSciences?
What is the all time high annual gross profit for Liminal BioSciences?
Liminal BioSciences all-time high annual gross profit is $17.98 M
What is the all time high quarterly gross profit for Liminal BioSciences?
Liminal BioSciences all-time high quarterly gross profit is $16.16 M
What is the all time high TTM gross profit for Liminal BioSciences?
Liminal BioSciences all-time high TTM gross profit is $20.93 M